X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216087
https://www.reuters.com/article/us-pharmamar-results/spains-pharmamar-posts-58-drop-in-9-mth-profit-despite-higher-revenues-idUSKBN2HI2DS
https://pharmamar.com/wp-content/uploads/2020/12/PR_PhM-R-Pharm_agreement_trabectedin_DEF.pdf
https://www.zawya.com/mena/en/press-releases/story/nbspSTADA_and_PharmaMar_signnbspagreement_to_commercialize_Yondelisregnbsptrabectedin_in_the_MENA_regionnbsp-ZAWYA20201117121507/
http://pharmamar.com/wp-content/uploads/2020/08/PR_PhM_Onko_agreement_DEF.pdf
https://www.ema.europa.eu/en/news/authorised-uses-cancer-medicine-yondelis-unchanged-following-review-new-data
https://www.ema.europa.eu/en/news/authorised-uses-cancer-medicine-yondelis-unchanged-following-review-new-data
http://pharmamar.com/wp-content/uploads/2020/05/NP_contrato_PhM-KeyOncologics_trabectedina_DEF.pdf
https://www.biospace.com/article/pharmamar-has-presented-results-of-its-antitumor-compounds-trabectedin-and-plocabulin-at-the-ctos-congress/?s=95
https://www.biospace.com/article/releases/sta-to-market-sarcoma-drug-in-australia-new-zealand-and-se-asia-following-license-deal/?s=95
https://www.biospace.com/article/the-importance-of-diversity-in-clinical-trials-because-right-now-it-s-lacking-/
http://www.prnewswire.com/news-releases/pharmamar-will-commercialize-pm1183-with-the-trade-name-of-zepsyre-628845343.html
http://www.pharmatimes.com/Article/15-11-25/NICE_ovarian_cancer_guideline_recommends_two_drugs_but_rejects_three.aspx
http://www.biospectrumasia.com/biospectrum/news/222490/soft-tissue-sarcoma-drug-approved-japan
http://www.pharmatimes.com/Article/15-02-03/Speedy_US_review_for_J_J_sarcoma_drug_Yondelis.aspx
http://www.prnewswire.com/news-releases/us-fda-grants-priority-review-for-yondelis-trabectedin-for-the-treatment-of-patients-with-advanced-soft-tissue-sarcoma-300029631.html
http://www.pharmatimes.com/Article/14-12-23/NICE_reviews_five_ovarian_cancer_drugs.aspx
Market Place
Share 
